Europe — EMA
Paracetamol/Codeïnefosfaat Accord Healthcare (Paracetamol, Codeine Phosphate Hemihydrate)
GNH USA supplies Paracetamol/Codeïnefosfaat Accord Healthcare (Paracetamol/Codeine), a analgesic combination for pain relief and fever reduction.
International sale not permitted. Listed for the domestic market and B2B only.
Request sourcing
What is Paracetamol, Codeine Phosphate Hemihydrate?
Paracetamol, the active ingredient in Paracetamol/Codeïnefosfaat Accord Healthcare, is an analgesic combination presented as a tablet for oral use. It treats mild to moderate pain and reduces fever in adults and children when appropriate. GNH USA supplies Paracetamol/Codeïnefosfaat Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
Paracetamol/Codeïnefosfaat Accord Healthcare is provided by GNH USA, a licensed, GDP‑compliant supplier to hospitals, pharmacies and clinics worldwide.
What is Paracetamol, Codeine Phosphate Hemihydrate used for?
Paracetamol/Codeine Phosphate Hemihydrate is used for pain relief in several common conditions where moderate analgesia is required. - Dental pain: provides effective relief of postoperative dental discomfort. - Musculoskeletal pain: reduces pain associated with strains, sprains and low‑back pain. - Headache and migraine: alleviates moderate intensity headache episodes. - Post‑operative pain: helps control pain after minor surgical procedures. - Fever: lowers elevated body temperature associated with infection or inflammation.
What are the side effects of Paracetamol, Codeine Phosphate Hemihydrate?
Paracetamol/Codeine Phosphate Hemihydrate may cause a range of adverse reactions, most of which are dose‑dependent and reversible.
Common Side Effects: - Nausea: mild to moderate stomach upset. - Constipation: reduced bowel movements. - Drowsiness: feeling of sleepiness or reduced alertness. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivary flow.
Serious or Rare Side Effects: - Respiratory depression: slowed breathing, especially at higher doses. - Hepatotoxicity: liver injury from excessive paracetamol exposure. - Allergic reactions: rash, itching, swelling or anaphylaxis. - Dependence or misuse: potential for opioid‑related dependence with prolonged use. - Seizures: rare occurrence, particularly in overdose situations.
What precautions apply to Paracetamol, Codeine Phosphate Hemihydrate?
When prescribing Paracetamol/Codeine Phosphate Hemihydrate, clinicians should consider several safety aspects. - Liver function: avoid use in patients with severe hepatic impairment. - Respiratory conditions: use cautiously in asthma or chronic obstructive pulmonary disease. - Opioid sensitivity: assess risk of dependence in patients with a history of substance abuse. - Pregnancy and lactation: limit use to situations where benefits outweigh risks. - Concomitant CNS depressants: monitor for enhanced sedation. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.
What does Paracetamol, Codeine Phosphate Hemihydrate interact with?
Paracetamol/Codeine Phosphate Hemihydrate can interact with several medicines, altering efficacy or safety.
Major Interactions (Avoid): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may reduce codeine conversion to active metabolite. - CNS depressants (e.g., benzodiazepines, alcohol): increase risk of respiratory depression. - MAO inhibitors: heightened risk of serotonin syndrome when combined with codeine.
Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Anticholinergic agents: may worsen constipation. - Diuretics: potential for reduced renal clearance of paracetamol.



